Can I Take Melatonin With Lisinopril? A Women's Health Guide

The Short Answer: Is Melatonin Safe With Lisinopril?

For the majority of women, taking a low-dose melatonin supplement alongside lisinopril does not produce a clinically dangerous interaction. There is no direct pharmacokinetic clash, meaning melatonin does not meaningfully change how your body absorbs, distributes, or clears lisinopril. The interaction that does exist is pharmacodynamic: both substances can influence blood pressure and, separately, melatonin can affect glucose handling in ways that matter if you have insulin resistance, PCOS, or type 2 diabetes managed alongside your blood-pressure therapy.

"unlikely to be dangerous" is not the same as "has no effect at all." Melatonin doses commonly sold in the United States, often 5 mg to 10 mg per tablet, are far higher than the doses used in clinical trials, and the blood-pressure effects of melatonin are dose- and timing-sensitive. Here is what the evidence actually shows.

How Melatonin Affects Blood Pressure (And Why It Matters With Lisinopril)

Melatonin's relationship with blood pressure is genuinely complex. Early studies suggested melatonin lowered nocturnal blood pressure; more recent controlled trials show the picture is murkier.

The Nocturnal Dipping Connection

Healthy blood pressure follows a circadian rhythm: it dips roughly 10 to 20 percent during sleep. Women who are non-dippers, meaning their BP stays elevated overnight, face higher cardiovascular risk. A 2004 randomized controlled trial in Hypertension found that 2.5 mg of controlled-release melatonin taken nightly for three weeks significantly reduced nighttime systolic BP by 6 mmHg and diastolic BP by 4 mmHg compared with placebo in hypertensive patients. That is a meaningful effect when you are already on an antihypertensive.

The Daytime or High-Dose Problem

Confusingly, some research suggests that daytime melatonin, or melatonin in doses above 5 mg, may acutely raise blood pressure in certain individuals by activating melatonin MT1 receptors in vascular smooth muscle. A systematic review published in Hypertension Research (2016) noted that melatonin's vascular effects are highly dependent on dose, formulation (immediate-release vs. Controlled-release), and the time of administration relative to sleep onset. The clinical bottom line: take melatonin close to bedtime, at the lowest effective dose, and monitor your blood pressure.

What This Means Alongside Lisinopril

Lisinopril lowers blood pressure by blocking angiotensin-converting enzyme, reducing angiotensin II, and relaxing blood vessels. If melatonin also lowers nocturnal BP, the two together could theoretically produce an additive effect and cause symptomatic hypotension (dizziness, lightheadedness, falls) in some women, especially those who are already well-controlled on lisinopril or who are on higher doses. The FDA prescribing information for lisinopril does not list melatonin as a contraindicated co-administration, but hypotensive episodes from additive agents are a known class concern with ACE inhibitors.

Practical steps: check your home BP within the first week after adding melatonin. If readings drop below 100/60 mmHg or you feel faint, contact your prescriber.

Melatonin, Glucose Tolerance, and Women With PCOS or Metabolic Syndrome

This is the interaction most clinical summaries skip, and it is particularly relevant for women.

The PCOS and Insulin-Resistance Angle

A 2021 meta-analysis in Reproductive Biology and Endocrinology found that women with PCOS have altered melatonin secretion patterns, with some studies showing lower nocturnal melatonin peaks. Supplementing melatonin in this group has produced mixed results on insulin sensitivity: some trials show modest improvement, while others show transient impairment of glucose tolerance at higher doses. Women with PCOS who are prescribed lisinopril for blood-pressure management (common in the context of metabolic syndrome) should be aware that melatonin could shift fasting glucose readings in either direction.

The Diabetes-Adjacent Risk

A controlled trial in Journal of Pineal Research (2006) showed that pharmacological doses of melatonin (above 3 mg) impaired glucose-stimulated insulin secretion in healthy volunteers. Many women taking lisinopril for hypertension also carry a diagnosis of prediabetes or type 2 diabetes. If that is your situation, add melatonin cautiously and monitor fasting glucose for two to four weeks after starting.

The WomanRx Three-Check Framework before adding melatonin to lisinopril:

1. Blood pressure check: record home BP at the same time each morning and evening for one week before starting melatonin, then for two weeks after.
2. Glucose check: if you have PCOS, prediabetes, or type 2 diabetes, check fasting glucose weekly for the first month.
3. Dose check: start at 0.5 mg to 1 mg immediate-release melatonin taken 30 to 60 minutes before sleep. Do not default to the 5 mg or 10 mg tablets commonly sold in pharmacies without clinical reason.

Pharmacokinetic Details: Does Melatonin Change How Lisinopril Works in Your Body?

No meaningful pharmacokinetic interaction has been demonstrated between melatonin and lisinopril. Lisinopril is not metabolized by cytochrome P450 enzymes. It is absorbed in the small intestine, does not undergo hepatic first-pass metabolism, and is excreted unchanged by the kidneys. Melatonin is metabolized primarily by CYP1A2 in the liver and has no known effect on renal transporters relevant to lisinopril clearance.

A 2022 review in British Journal of Clinical Pharmacology confirmed that melatonin's principal drug interactions involve CYP1A2 inducers or inhibitors (such as fluvoxamine or smoking) rather than renally cleared drugs like lisinopril. So the concern with this combination is cardiovascular and metabolic, not about one drug interfering with the blood levels of the other.

Women-Specific Physiology: How Life Stage Changes This Calculation

Reproductive Years and Menstrual Cycle Variation

Melatonin secretion varies across the menstrual cycle. Levels tend to be slightly higher in the luteal phase. Women of reproductive age who use melatonin to manage shift-work sleep disorder or jet lag while on lisinopril for hypertension should know that the blood-pressure effect of melatonin may be subtly more pronounced in the luteal phase. There are no large trials in this specific population, so this is an extrapolation from melatonin physiology rather than direct evidence. That evidence gap is real and worth naming.

Perimenopause and Menopause

Sleep disruption is one of the most common and new symptoms of perimenopause. The Menopause Society (formerly NAMS) 2023 position statement on menopause management notes that sleep disturbance affects up to 60 percent of perimenopausal women. This makes melatonin a frequently reached-for solution in this group, and perimenopausal women also have rising rates of hypertension, making co-prescription of lisinopril common.

Estrogen decline changes vascular tone and blunts nocturnal BP dipping. Adding melatonin in a perimenopausal woman on lisinopril who is already a non-dipper could produce a more pronounced nighttime BP reduction than expected. Home BP monitoring is not optional in this group. It is the practical standard of care.

Postpartum Period

Hypertension can persist or newly emerge postpartum, and lisinopril is used in this setting. New mothers reaching for melatonin for postpartum sleep disruption need to read the next section carefully.

Pregnancy and Lactation Safety: Read This First

Lisinopril is contraindicated in pregnancy. This is not a relative contraindication. The FDA label for lisinopril carries a black-box warning stating that ACE inhibitors can cause fetal injury and death when administered to pregnant women. Exposure during the second and third trimesters causes fetal renal dysfunction, oligohydramnios, limb contractures, craniofacial deformities, and neonatal death. Exposure in the first trimester is associated with cardiac malformations in some observational data.

If you are on lisinopril and could become pregnant, you must use reliable contraception. This means a method with a typical-use failure rate below 1 percent per year, such as an IUD, implant, or combined oral contraceptive (with the understanding that oral contraceptives can modestly raise blood pressure and your prescriber needs to know). ACOG Practice Bulletin on Chronic Hypertension in Pregnancy (No. 203) recommends switching to pregnancy-compatible antihypertensives (labetalol, nifedipine, methyldopa) before conception.

If you discover you are pregnant while taking lisinopril, stop it immediately and call your OB-GYN or midwife the same day.

Melatonin in Pregnancy

Melatonin is not recommended during pregnancy. Human safety data are insufficient. A 2019 review in Nutrients found that while animal studies suggest melatonin may have a neuroprotective role in the fetal brain, there are no adequate, well-controlled trials in pregnant women. Given that both substances are contraindicated or not recommended in pregnancy, the combined question is moot: neither should be used during pregnancy without explicit specialist guidance.

Melatonin During Breastfeeding

Melatonin is naturally present in breast milk in low quantities and follows a circadian pattern with peak levels at night. A review in Nutrients (2019) notes that the infant dose from maternal supplementation is uncertain because pharmacological doses in maternal serum are much higher than physiological secretion. Most lactation specialists advise against supplemental melatonin during breastfeeding until more data exist. Lisinopril is excreted in breast milk in small amounts; LactMed (NIH) lists it as probably compatible with breastfeeding but recommends monitoring the infant for signs of hypotension.

Who This Combination Is Reasonable For (and Who Should Be More Cautious)

Probably Reasonable With Monitoring

Women who fit this profile can generally try low-dose melatonin (0.5 mg to 3 mg) alongside lisinopril with standard monitoring:

• Postmenopausal women with well-controlled hypertension on a stable lisinopril dose, using melatonin short-term for jet lag or shift-work adjustment.
• Perimenopausal women with mild sleep disruption, stable BP, no diabetes, and no dizziness on their current lisinopril dose.
• Women on low-dose lisinopril (5 mg to 10 mg/day) with BP consistently in the 120 to 130/70 to 80 mmHg range who have headroom before hypotension becomes a concern.

More Cautious Approach Warranted

Some women should have an explicit conversation with their prescriber before adding melatonin:

• Women on higher lisinopril doses (20 mg to 40 mg/day) or who also take a diuretic, calcium-channel blocker, or beta-blocker, because additive hypotension risk stacks up across agents.
• Women with PCOS or type 2 diabetes, given melatonin's potential effects on glucose.
• Women with chronic kidney disease (CKD), since lisinopril is used as a renoprotective agent in CKD and sleep architecture in CKD is already disrupted in ways that change melatonin physiology.
• Women with known non-dipping nocturnal BP pattern confirmed on ambulatory BP monitoring.

Not Appropriate

• Pregnant women. Stop both if pregnant; seek immediate care.
• Women actively breastfeeding, without explicit guidance from their care team.

Practical Dosing and Timing Guidance

The doses of melatonin on pharmacy shelves in the United States are often 5 mg, 10 mg, or even 20 mg, none of which are the doses used in the trials showing cardiovascular benefit. A consensus statement from the American Academy of Sleep Medicine recommends melatonin doses of 0.5 mg to 5 mg for circadian disorders, with the caveat that lower doses are often as effective as higher ones for sleep-onset latency.

Start at 0.5 mg. Take it 30 to 60 minutes before your intended sleep time. Do not take it in the morning or afternoon. Do not use it nightly for more than two to four weeks without reassessing with your prescriber. This is not a supplement designed for indefinite daily use alongside an antihypertensive without periodic review.

If you currently take lisinopril in the evening (some women do to maximize nocturnal BP control), check with your prescriber whether shifting lisinopril to morning dosing might reduce the overlap with melatonin's peak cardiovascular effect window.

Evidence Gaps and What Is Still Unknown

Women have been underrepresented in most trials on melatonin and blood pressure. The 2004 Hypertension trial by Scheer et al. included both sexes but did not report sex-stratified outcomes. Most melatonin-glucose interaction studies enrolled predominantly male participants. The interaction between melatonin and ACE inhibitors has not been studied in a dedicated randomized controlled trial in any population, let alone specifically in perimenopausal or postmenopausal women with hypertension.

This means the guidance in this article, and in every other resource on this topic, is partly extrapolated from melatonin's general pharmacology and from ACE inhibitor class effects. Acknowledging that gap is not a reason to panic. It is a reason to monitor, start low, and keep your prescriber in the loop.

As Dr. Maya Okafor, MD, WomanRx medical reviewer, notes: "The real clinical concern with melatonin and lisinopril is not a dramatic drug-drug interaction. It is the cumulative blood-pressure effect in women who are already well-controlled, and the glucose effects in women with PCOS or metabolic syndrome who often get missed in the standard interaction databases."

What to Tell Your Doctor or NP

Bring this list to your next visit or message through your telehealth portal:

• The dose and brand of melatonin you are considering or already taking.
• Your most recent home BP readings (bring at least one week of data).
• Whether you have PCOS, prediabetes, type 2 diabetes, or CKD.
• Your current lisinopril dose and any other antihypertensives you take.
• Your life stage: trying to conceive, pregnant, postpartum, perimenopausal, or postmenopausal.
• Whether you are using any form of hormonal contraception, since some methods affect blood pressure and melatonin clearance.

If your provider dismisses the question without engaging with your specific BP numbers and life stage, that is worth pushing back on.